Cleared Abbreviated

K071446 - ELECTRODE ARRAY CAP

K071446 is an FDA 510(k) clearance for ELECTRODE ARRAY CAP, manufactured by Electrode Arrays. The device is a Class 2 Neurology device with product code GXY cleared through the Abbreviated 510(k) pathway after a 405-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2008
Decision
405d
Days
Class 2
Risk

K071446 is an FDA 510(k) clearance for the ELECTRODE ARRAY CAP. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Electrode Arrays (El Paso, US). The FDA issued a Cleared decision on July 2, 2008 after a review of 405 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: High-complexity regulatory submission. Standards-verified equivalence. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Electrode Arrays devices

FDA 510(k) Submission Details - K071446

510(k) Number K071446 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2007
Decision Date July 02, 2008
Days to Decision 405 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
257d slower than avg
Panel avg: 148d · This submission: 405d
Pathway characteristics
Standards-based clearance path.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 249
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K071446.
UNIVERSAL ELECTRODES
K083818 · Neurometrix, Inc. · Jan 2009
GE ENTROPY SENSOR
K082540 · Ge Healthcare · Nov 2008
UNIVERSAL ELECTRODES
K081871 · Neurometrix, Inc. · Sep 2008
GE ENTROPY SENSOR (REFM1038681) AND GE ENTROPY CABLE (REF M1050784)
K062580 · Ge Healthcare · Dec 2007
ZIPPREP ELECTRODE
K070069 · Aspect Medical Systems, Inc. · Feb 2007
BIS BILATERAL SENSOR
K062692 · Aspect Medical Systems, Inc. · Dec 2006